Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplastic Conditions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04720768
What this trial is testing

Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE

Who this might be right for
MelanomaMetastasis
Peter MacCallum Cancer Centre, Australia 78
Early research (Phase 1)Ended earlyNCT03871348
What this trial is testing

A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic Neoplasm
Sanofi 77
Not applicableStudy completedNCT01083849
What this trial is testing

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

Who this might be right for
Kidney InsufficiencySecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 761
Testing effectiveness (Phase 2)Active Not RecruitingNCT02671435
What this trial is testing

Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 383
Early research (Phase 1)Study completedNCT05279690
What this trial is testing

Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urothelial CancerMetastatic Solid Tumor
Icahn School of Medicine at Mount Sinai 16
Early research (Phase 1)Active Not RecruitingNCT05717348
What this trial is testing

ES014 in Patients With Locally Advanced or Metastatic Solid Tumours

Who this might be right for
Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor
Elpiscience (Suzhou) Biopharma, Ltd. 120
Not applicableUnknownNCT06441240
What this trial is testing

Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.

Who this might be right for
Breast CancerChemotherapy EffectTriple Negative Breast Cancer+2 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 933
Testing effectiveness (Phase 2)Looking for participantsNCT07486089
What this trial is testing

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)HER2-positive Breast CancerTriple-Negative Breast Cancer (TNBC)
Beijing Biotech 60
Not applicableStudy completedNCT01764789
What this trial is testing

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Who this might be right for
Anxiety DisorderDepressionFatigue+17 more
Ohio State University Comprehensive Cancer Center 39
Very early researchStudy completedNCT03928210
What this trial is testing

Digoxin Induced Dissolution of CTC Clusters

Who this might be right for
Breast CancerCirculating Tumor Cells (CTCs)
University Hospital, Basel, Switzerland 58
Large-scale testing (Phase 3)WithdrawnNCT03811418
What this trial is testing

Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CancerHER2-positive Breast Cancer
iOMEDICO AG
Not applicableUnknownNCT02951897
What this trial is testing

Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma, Stage IDiagnoses DiseasesCirculating Tumor Cells+1 more
Third Military Medical University 120
Not applicableUnknownNCT05059782
What this trial is testing

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Who this might be right for
Ovarian CancerNeoplasm, OvarianOvarian Neoplasm+14 more
Xi'an Jiaotong University 150
Early research (Phase 1)Study completedNCT03017833
What this trial is testing

Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 31
Post-approval studies (Phase 4)Ended earlyNCT01266291
What this trial is testing

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

Who this might be right for
Complex Partial Seizures
University of Pennsylvania 1
Testing effectiveness (Phase 2)Ended earlyNCT00318110
What this trial is testing

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Center for International Blood and Marrow Transplant Research 4
Testing effectiveness (Phase 2)Ended earlyNCT00601848
What this trial is testing

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Who this might be right for
Lung CancerMetastatic Cancer
Abramson Cancer Center at Penn Medicine 9
Not applicableNot Yet RecruitingNCT07474025
What this trial is testing

Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses

Who this might be right for
Peritoneal (Metastatic) CancerColorectal CancerColorectal (Colon or Rectal) Cancer+1 more
Jules Bordet Institute 30
Large-scale testing (Phase 3)Ended earlyNCT03326674
What this trial is testing

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 685
Early research (Phase 1)Study completedNCT05087992
What this trial is testing

Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers

Who this might be right for
Gastrointestinal Cancer, Metastatic
Boehringer Ingelheim 13
Next Page